네오크레마
311390KOSDAQ65.8 / 100
Reference Date: 2026-09-08
Company InformationBased on 2025 Annual Report
Business Overview
Neocrema is a functional food ingredient company specializing in microbiome-based products, producing functional sugars and peptides that offer health benefits such as gut environment improvement and blood sugar suppression. Through its subsidiary BB&C, the company diversifies its portfolio with materials and healthcare products, while expanding its market by developing alternative sweeteners and researching skin microbiota. The company also holds international certifications like Halal and Kosher for global exports.
Number of Employees
70people
Average Salary
54.9M KRW
Score Calculation Basis
Detailed Financial Score
Lower than industry avg (good)
Half of industry avg (excellent)
Well below industry avg
Half of industry avg (excellent)
Avg ▲82.7% (2-year basis)
Avg ▲267.7% (2-year basis)
Avg ROE -2.3% (improving, 3yr)
Detailed News Sentiment
- Positive네오크레마, 2분기 매출 228억원 '사상 최대'… 별도 영업익도 흑자...
네오크레마의 2분기 매출이 사상 최대치를 기록하며 성장세를 입증했다.
Detailed Momentum
Near 52w low (2%, downtrend)
1m +2.55% (slight rise)
Volume decreasing
Detailed Disclosure
- Neutral반기보고서 (2026.06)2026-08-14
